Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
Costof Revenue Total | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 |
Selling/ General/ Admin Expenses Total | 0.10 | 0.09 | 0.06 | 0.05 |
Depreciation/ Amortization | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Expenses Total | 0.09 | 0.09 | 0.10 | 0.11 |
Total Operating Expense | 0.19 | 0.18 | 0.16 | 0.17 |
Operating Income | -0.19 | -0.18 | -0.16 | -0.17 |
Interest Inc( Exp) Net- Non- Op Total | 1.28 | 0.77 | -0.06 | -0.69 |
Other Net | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income Before Taxes | -0.06 | -0.10 | -3.86 | -0.24 |
Provisionfor Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income After Taxes | -0.06 | -0.10 | -3.86 | -0.24 |
Net Income Before Extra Items | -0.06 | -0.10 | -3.86 | -0.24 |
Net Income | -0.06 | -0.10 | -3.86 | -0.24 |
Income Availableto Com Excl Extra Ord | -0.06 | -0.10 | -3.86 | -0.24 |
Income Availableto Com Incl Extra Ord | -0.06 | -0.10 | -3.86 | -0.24 |
Diluted Net Income | -0.06 | -0.10 | -3.86 | -0.24 |
Diluted Weighted Average Shares | 0.59 | 0.60 | 0.59 | 0.58 |
Diluted EPS Excluding Extra Ord Items | -0.10 | -0.17 | -6.55 | -0.41 |
Diluted Normalized EPS | -0.10 | -0.17 | -2.47 | -0.41 |
Gain( Loss)on Saleof Assets | - | 0.00 | -36.95 | - |
Bacil Pharma Dividend Bacil Pharma Bonus Bacil Pharma News Bacil Pharma AGM Bacil Pharma Rights Bacil Pharma Splits Bacil Pharma Board Meetings Bacil Pharma Key Metrics Bacil Pharma Shareholdings Bacil Pharma Balance Sheet Bacil Pharma Cashflow Bacil Pharma Q1 Results Bacil Pharma Q2 Results Bacil Pharma Q3 Results Bacil Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks